---
audienceLevel: patient
cancerTypes:
- colorectal
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Trifluridine and Tipiracil Hydrochloride - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/trifluridine-tipiracilhydrochloride
version: v1
---

# Trifluridine and Tipiracil Hydrochloride - NCI

# Trifluridine and Tipiracil Hydrochloride

Placeholder slot

(try-FLOOR-ih-deen â€¦ ty-PEER-uh-sil HY-droh-KLOR-ide)

This chemotherapy combination contains the drugs trifluridine and tipiracil hydrochloride. Trifluridine enters cells and gets incorporated into the DNA, which keeps it from being copied. This stops cells from dividing. Tipiracil hydrochloride prevents trifluridine from being broken down in the body so it can kill more cancer cells.

US Brand Name(s)

Lonsurf

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5beed22-d71d-4c0d-8dca-2c7317d65d85&audience=consumer)

## Use in Cancer

Trifluridine and tipiracil hydrochloride
is approved to treat adults with:

- **[Colorectal cancer](/Common/PopUps/popDefinition.aspx?id=444983&version=Patient&language=English)** that has spread to other parts of the body. It is used alone or with [bevacizumab](/Common/PopUps/popDefinition.aspx?id=46115&version=Patient&language=English) in patients who have already been treated with a [fluoropyrimidine](/Common/PopUps/popDefinition.aspx?id=386207&version=Patient&language=English), [oxaliplatin](/Common/PopUps/popDefinition.aspx?id=45465&version=Patient&language=English), [irinotecan hydrochloride](/Common/PopUps/popDefinition.aspx?id=635811&version=Patient&language=English), and a [VEGF](/Common/PopUps/popDefinition.aspx?id=44474&version=Patient&language=English) [inhibitor](/Common/PopUps/popDefinition.aspx?id=46739&version=Patient&language=English). Patients whose cancer has the [wild-type KRAS gene](/Common/PopUps/popDefinition.aspx?id=785884&version=Patient&language=English) should have also received an [EGFR inhibitor](/Common/PopUps/popDefinition.aspx?id=532303&version=Patient&language=English).
- **[Stomach](/Common/PopUps/popDefinition.aspx?id=445087&version=Patient&language=English) [adenocarcinoma](/Common/PopUps/popDefinition.aspx?id=46216&version=Patient&language=English)** or **[gastroesophageal junction](/Common/PopUps/popDefinition.aspx?id=302458&version=Patient&language=English) adenocarcinoma** (a rare type of [esophageal cancer](/Common/PopUps/popDefinition.aspx?id=444989&version=Patient&language=English)) that has spread to other parts of the body. It is used in patients who have already received at least two treatments with a fluoropyrimidine and [platinum](/Common/PopUps/popDefinition.aspx?id=45841&version=Patient&language=English) [chemotherapy](/Common/PopUps/popDefinition.aspx?id=45214&version=Patient&language=English) and either a [taxane](/Common/PopUps/popDefinition.aspx?id=46138&version=Patient&language=English) or irinotecan and, in some cases, [HER2/neu](/Common/PopUps/popDefinition.aspx?id=44945&version=Patient&language=English)-[targeted therapy](/Common/PopUps/popDefinition.aspx?id=270742&version=Patient&language=English).

Trifluridine and tipiracil hydrochloride
is also being studied in the treatment of other types of
cancer.

## More About Trifluridine and Tipiracil Hydrochloride

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/734891) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Trifluridine and Tipiracil Hydrochloride](https://medlineplus.gov/druginfo/meds/a615049.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Drug Combination May Have Potential for Cancers with TP53 Mutations](https://www.cancer.gov/news-events/cancer-currents-blog/2024/lonsurf-talzenna-cancer-tp53-mutations)

[Drug Regimen Boosts Survival of People with Advanced Colorectal Cancer](https://www.cancer.gov/news-events/cancer-currents-blog/2023/avastin-lonsurf-improves-survival-colorectal-cancer)

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Trifluridine And Tipiracil Hydrochloride](https://www.cancer.gov/research/participate/clinical-trials/intervention/C102554) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
